Skip navigation
BelSU DSpace logo

Browsing by Subject erythropoietin

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z А Б В Г Д Е Ж З И Й К Л М Н О П Р С Т У Ф Х Ц Ч Ш Щ Ъ Ы Ь Э Ю Я
or enter first few letters:  
Showing results 1 to 14 of 14
Issue DateTitleAuthor(s)
2016Correction of ischemic damage to the retina on application of pharmacological preconditioning of recombinant erythropoietinShabelnikova, A. S.
2020Eleven-amino acid peptides that mimic the erythropoietin α-helix B increases cell survival in endotheliocyte cultureAntsiferov, O. V.; Korokin, M. V.; Gureev, V. V.; Pokrovskii, M. V.; Korokina, L. V.; Gudyrev, O. S.; Pokrovskaia, T. G.
2020Endothelial protective properties of short-chain peptides that mimic α-helix B of erythropoietin in experimental preeclampsiaGolubev, I. V.; Gureev, V. V.; Korokin, M. V.; Gureeva, A. V.; Polyanskaya, A. V.; Pokrovskii, M. V.; Lazareva, G. A.; Bystrova, N. A.
2020Erythropoietin mimetic peptide (pHBSP) corrects endothelial dysfunction in a rat model of preeclampsiaKorokin, M.; Gureev, V.; Gudyrev, O.; Golubev, I.; Korokina, L.; Peresypkina, A.; Pokrovskaia, T.
2018Evaluation of carbamylated darbepoetin acute toxicityKolesnichenko, P. D.; Gudyrev, O. S.; Zhuchenko, M. A.; Zhernakova, N. I.; Faitelson, A. V.
2020Non-hematopoietic erythropoietin-derived peptides for atheroprotection and treatment of cardiovascular diseasesBelyaeva, V. S.; Stepenko, Yu. V.; Kulikov, A. L.; Kochkarova, I. S.; Martynova, O. V.; Pokrovskiy, M. V.
2018Pharmacological correction of retinal ischemia/reperfusion by minoxidilPeresypkina, A. A.; Gubareva, V. O.; Levkova, E. A.; Shabelnikova, A. S.; Pokrovskii, M. V.
2018Pharmacological correction of retinal ischemia/reperfusion by minoxidilPeresypkina, A. A.; Gubareva, V. O.; Levkova, E. A.; Shabelnikova, A. S.; Pokrovskii, M. V.
2019Pharmacological modulation of cell functional activity with valproic acid and erythropoietinGolubinskaya, P. A.; Sarycheva, M. V.; Burda, S. Y.; Puzanov, M. V.; Nadezhdina, N. A.
2016Pharmacological preconditioning by recombinant erythropoietin as the possibility of increasing the stability of tissue of the retina to reperfusion ischemia in experimentShabelnikova, A. S.; Peresypkina, A. A.; Gubareva, V. O.; Levkova, E. A.; Dolzhikov, A. A.
2019Pleiotropic effects of erythropoietin. Influence of erythropoietin on processes of mesenchymal stem cells differentiationZubareva, E. V.; Nadezhdin, S. V.; Burda, Y. E.; Nadezhdina, N. A.; Gashevskaya, A. S.
2017Search of new pharmaceuticals on the basis of darbepoetin in the treatment of ischemic stroke: review of literatureReznikov, K. M.; Gorbunova, N. S.; Kolesnichenko, P. D.; Tverskoy, A. V.; Kostina, D. A.
2022Study of the anti-inflammatory and immunotropic activity of the secretome from multipotent mesenchymal stromal cells induced by erythropoietin, valproic acid or dexamethasone in vitroGolubinskaya, P. A.; Puzanov, M. V.; Sarycheva, M. V.; Burda, S. Yu.; Nadezhdin, S. V.; Korokin, M. V.
2020The anti-aggregation activity of new 11-amino acid of erythropoietin derivate containing tripeptide motifsGolubev, I. V.; Gureev, V. V.; Korokina, L. V.; Gudyrev, O. S.; Pokrovskaia, T. G.; Pokopeiko, O. N.